在急性心血管疾病中估计乳酸减少的时间框架,使用基于非线性混合效应模型的功能数据分析
Takaya Nakashima1, Shuntaro Sato2, Hidetoshi Matsui3
1Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences.
International heart journal
|December 1, 2024
概括
降低乳酸水平是急性心血管疾病预后的关键. 这项研究在急性心力衰竭,大动脉剖析和缺血性心脏病患者中发现了乳酸减少时间框架的显著差异.
科学领域:
- 心脏病学 心脏病学
- 密集护理医学 密集护理医学
- 生物统计学 生物统计学
背景情况:
- 乳酸盐水平的监测对于急性心血管疾病的预后至关重要.
- 乳酸减少趋势为患者状况评估提供了洞察力.
- 特定的心血管疾病可能表现出不同的乳酸清除模式.
研究的目的:
- 估计急性心力衰竭,大动脉剖析和缺血性心脏病患者乳酸减少的时间框架.
- 用功能数据分析和非线性混合效应模型分析乳酸水平趋势.
- 提供数据,以根据疾病特定的乳酸减少率制定量身定制的治疗计划.
主要方法:
- 使用非线性混合效应模型的功能数据分析.
- 分析了1249名被诊断患有急性心力衰竭,大动脉剖析或缺血性心脏病的成年患者的乳酸趋势.
- 从2010年12月至2020年6月期间入住重症监护病房的患者收集了数据.
主要成果:
- 乳酸减少的时间框架因心血管疾病而异.
- 急性心力衰竭患者在30小时内显示出乳酸减少 (95% CI,23-37小时).
- 大动脉剖析患者需要40小时 (95% CI,33-47小时) 的乳酸减少.
- 缺血性心脏病患者表现出最长的乳酸减少时间框架95小时 (95% CI,49-失败估计).
结论:
- 该研究成功估计了心血管病患者的疾病特异性乳酸减少时间框架.
- 认识到这些差异可以为开发个性化治疗策略提供信息.
- 了解乳酸动力学对于优化关键心血管疾病患者的治疗结果至关重要.
相关概念视频
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
01:15Pharmacodynamic Models: Logarithmic Concentration–Effect Model
The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...